Opportunity Radar

← Back to search

Grant

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
RFA-DA-25-060
Posted
Jan 17, 2024
Response due
Mar 5, 2027
Archive date
Apr 5, 2027
CFDA / Assistance listing
93.279
Award ceiling
$1,500,000
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Similar open opportunities